Effect of Dexamethasone on Ventilator-Free Days in Patients With Moderate or Severe COVID-19 –Related ARDS

This open label clinical trial compares the effects of dexamethasone vs usual care on the number of days alive and free of mechanical ventilation at day 28 among COVID-19 patients in Brazil with moderate to severe acute respiratory distress syndrome (ARDS).
Source: JAMA - Journal of the American Medical Association - Category: General Medicine Source Type: research